Tower Research Capital (TRC)’s Beam Therapeutics BEAM Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$136K	Buy	5,702 +3,718	+187%	+$103K	﹤0.01%	1936
2025 Q4	$55K	Sell	1,984 -73,310	-97%	-$1.87M	﹤0.01%	2347
2025 Q3	$1.83M	Buy	75,294 +43,406	+136%	+$864K	0.05%	315
2025 Q2	$542K	Buy	31,888 +16,935	+113%	+$295K	0.01%	914
2025 Q1	$292K	Buy	14,953 +13,581	+990%	+$356K	0.01%	1158
2024 Q4	$34K	Sell	1,372 -5,172	-79%	-$132K	﹤0.01%	2813
2024 Q3	$160K	Sell	6,544 -21,819	-77%	-$564K	﹤0.01%	1825
2024 Q2	$665K	Buy	28,363 +22,319	+369%	+$548K	0.01%	1086
2024 Q1	$200K	Sell	6,044 -218	-3%	-$6.79K	﹤0.01%	1413
2023 Q4	$170K	Buy	6,262 +2,168	+53%	+$53.9K	﹤0.01%	2231
2023 Q3	$98.5K	Sell	4,094 -7,325	-64%	-$196K	﹤0.01%	1990
2023 Q2	$365K	Buy	11,419 +5,759	+102%	+$187K	0.01%	1176
2023 Q1	$173K	Buy	5,660 +4,090	+261%	+$161K	0.01%	1448
2022 Q4	$61K	Sell	1,570 -32,893	-95%	-$1.47M	﹤0.01%	2188
2022 Q3	$1.64M	Buy	34,463 +10,281	+43%	+$586K	0.03%	495
2022 Q2	$936K	Buy	24,182 +1,433	+6%	+$57K	0.02%	735
2022 Q1	$1.3M	Buy	22,749 +20,059	+746%	+$1.32M	0.01%	701
2021 Q4	$215K	Sell	2,690 -1,626	-38%	-$139K	﹤0.01%	1708
2021 Q3	$376K	Buy	4,316 +2,121	+97%	+$213K	0.01%	1195
2021 Q2	$283K	Sell	2,195 -19,370	-90%	-$1.54M	0.01%	1642
2021 Q1	$1.73M	Buy	21,565 +18,075	+518%	+$1.72M	0.03%	535
2020 Q4	$285K	Sell	3,490 -14,349	-80%	-$706K	0.01%	1431
2020 Q3	$439K	Buy	17,839 +15,225	+582%	+$378K	﹤0.01%	1824
2020 Q2	$73K	Buy	+2,614	New	+$56.3K	﹤0.01%	2739